Fundz

One2Treat raised an undisclosed amount in Seed extension funding to expand operations and development efforts, led by CEO Sébastien Coppe.

PRIVATESep 04, 2025

Round Type

Seed

Louvain-la-NeuveBiotechnologyHealth Careresearch

Description

One2Treat, a technology company from Louvain-La-Neuve, Belgium, raised undisclosed funds in a Seed extension round. The company intends to use the funds to enhance its operations and development efforts. They provide a software platform that integrates patient voices into clinical development. This funding follows the deployment of their One2Treat Insights module and the release of the One2Treat Voice module.

Quick answer

One2Treat raised an undisclosed amount in a Seed round, dated September 4, 2025. One2Treat is based in Louvain-la-Neuve, Wallonie, Belgium.

How much did One2Treat raise?
One2Treat raised an undisclosed amount in a Seed round on September 4, 2025.
What does One2Treat do?
One2Treat is a forward-thinking partner for biopharmaceutical companies, dedicated to delivering transformative insights in clinical trial design, analysis, and market access evaluations to support holistic treatment..
Where is One2Treat based and how big is it?
One2Treat is based in Louvain-la-Neuve, Wallonie, Belgium. Fundz records about 12 employees.
Who are the decision-makers at One2Treat?
Fundz holds 1 contact at One2Treat. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in research and Biotechnology around the same time

Companies in the same sectors as One2Treat that raised within 45 days of this round, from Fundz verified event records.

  • Adcytherix raised $122M (Series A) on October 16, 2025.
  • Bexorg raised $23M (Series A) on October 16, 2025.
  • Kardigan raised $254M (Series B) on October 14, 2025.
  • Expedition Therapeutics raised $165M (Series A) on October 9, 2025.
  • BioRestorative Therapies raised $14M (Seed) on October 8, 2025.
  • Kernal Biologics raised $48M (Funding Round) on October 7, 2025.

Who to call at One2Treat, and when

A new round usually means One2Treat is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day One2Treat raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at One2Treat, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at One2Treat. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

One2Treat

Location

Louvain-la-Neuve, Wallonie, Belgium

About

One2Treat is a forward-thinking partner for biopharmaceutical companies, dedicated to delivering transformative insights in clinical trial design, analysis, and market access evaluations to support holistic treatment decisions. One2Treat was founded in July 2023 after four years of advanced Research and Software Development incubation within IDDI Group.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment One2Treat raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for One2Treat's next move

See what Strategic adds

One2Treat raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.